C
China Shineway Pharmaceutical Group Ltd
OTC:CSWYY
China Shineway Pharmaceutical Group Ltd
OTC:CSWYY
Price:
19.25
USD
Market Closed
Market Cap:
$727.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
China Shineway Pharmaceutical Group Ltd
OTC:CSWYY
|
CN |
|
AfriTin Mining Ltd
LSE:ATM
|
GG |
|
Cactus Inc
NYSE:WHD
|
US |
|
S
|
Sicily By Car SpA
MIL:SBC
|
IT |
|
O
|
Oriental Union Chemical Corp
TWSE:1710
|
TW |
|
Ausgold Ltd
ASX:AUC
|
AU |
|
G
|
Green Brick Partners Inc
NYSE:GRBK
|
US |
|
D
|
Datamatics Global Services Ltd
NSE:DATAMATICS
|
IN |
|
Kent Gida Maddeleri Sanayii ve Ticaret AS
IST:KENT.E
|
TR |
|
S
|
Super Group Ltd
JSE:SPG
|
ZA |
|
Avic Aviation High Technology Co Ltd
SSE:600862
|
CN |
|
Intelbras SA Industria de Telecomunicacao Eletronica Brasileira
BOVESPA:INTB3
|
BR |
|
Q
|
Quartiers Properties AB (publ)
STO:QUART PREF
|
SE |
|
F
|
Finatext Holdings Ltd
TSE:4419
|
JP |
|
Japan Cash Machine Co Ltd
TSE:6418
|
JP |
|
Welby Inc
TSE:4438
|
JP |
|
Claros Mortgage Trust Inc
NYSE:CMTG
|
US |
|
BCC Co Ltd
TSE:7376
|
JP |
|
Precision Camshafts Ltd
NSE:PRECAM
|
IN |
|
R
|
Ridge-i Inc
TSE:5572
|
JP |
Relative Value
The Relative Value of one CSWYY stock under the Base Case scenario is hidden USD. Compared to the current market price of 19.25 USD, China Shineway Pharmaceutical Group Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CSWYY Relative Value
HIDDEN
Multiples Across Competitors
CSWYY Competitors Multiples
China Shineway Pharmaceutical Group Ltd Competitors
China Shineway Pharmaceutical Group Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
C
|
China Shineway Pharmaceutical Group Ltd
OTC:CSWYY
|
7.4B USD | 1.9 | 7.7 | -0.3 | -0.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.1 | 41.5 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP | 4.9 | 28.3 | 15.7 | 22.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.2B CHF | 5.1 | 20.5 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
